Aryl and heteroaryl-fused tetrahydro-1,4-oxazepine amides as somatostatin receptor subtype 4 (SSTR4) agonists
申请人:Boehringer Ingelheim International GmbH
公开号:US10183940B2
公开(公告)日:2019-01-22
The invention relates to aryl and heteroaryl-fused tetrahydro-1,4-oxazepine amide derivatives of general formula (1), which are agonists of somatostatin receptor subtype 4 (SSTR4), useful for preventing or treating medical disorders related to SSTR4. In addition, the invention relates processes for manufacture of the compounds according to the invention.
本发明涉及通式(1)的芳基和杂芳基融合的四氢-1,4-氧氮杂卓酰胺衍生物,它们是体生长激素受体亚型 4(SSTR4)的激动剂,可用于预防或治疗与 SSTR4 有关的疾病。此外,本发明还涉及根据本发明的化合物的制造工艺。